Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Paramount settles with US states in big step towards closing Warner Bros merger, source says
By Jody Godoy and Deborah Mary Sophia Sept 21 (Reuters) - Paramount Skydance emerged victorious…
China's Z.ai disables AI coding assistant features after security issue
By Laurie Chen BEIJING, Sept 21 (Reuters) - Chinese startup Z.ai said on Monday it…
Google opens pre-orders for $899 Googlebook laptops built around Gemini AI
Sept 21 (Reuters) - Alphabet's Google on Monday opened pre-orders for Googlebook, its new premium…
